article thumbnail

Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD

Digital Health Global

About Tris Pharma Tris Pharma is a privately held, innovation-driven biopharmaceutical company that is applying its drug development capabilities and proprietary technologies to transform the treatment of ADHD, pain and neurological disorders, including addiction and diseases of the central nervous system. About Braingaze Ltd.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Let’s look back even further to 2013 to examine one definition of patient engagement: Health Affairs defines patient engagement as combining patient activation with interventions designed to increase and promote positive patient behavior, such as obtaining preventive care or exercising regularly, hopefully to lower costs.

BioTech 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more

Healthcare IT Today

Cybersecurity company Surfshark found the number of government requests for user data increased 4x from 2013 to 2020 among Apple, Google, Facebook, and Microsoft. While 7 out of 10,000 may not seem like a lot, a large hospital with up to 20 connected devices per patient room could have several devices at risk.

eCare 93
article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

In 2013, Teladoc went public on the NYSE. As the ability to collect and analyze large amounts of patient data grows, there is a growing opportunity for companies to develop personalized treatments and care plans. This could create a company that is able to develop and deliver personalized treatments to patients.